This crticial issues concerning Walitt has to be addressed by the NIH. Otherwise, you could end up having a 'kangaroo court' type research trial.
Brian Walitt on the NIH study.
#MEAction is sharing all of the comments on that page with NIH. We have received text submissions for a few petitions, and will try to finish a single petition incorporating everyone's input in the next few days. I do believe that official channels will help though since NIH is now listening and (slowly.....) setting up communication processes. I realize I may be wrong, but I don't think this will be like the Lancet where Horton ignored all the controversy and said he couldn't respond because he was on vacation.Ok but maybe before we go viral is there a more direct way ? I think it's better to try official channels first. Petitions and social media are for getting attention, but if we have a channel to the NIH either via Lipkin or the patient advisory committee we should try that first I think.
(I'd have more time and be more practically helpful with this advocacy if I wasn't working on a project targeting the Canadian problem.)
By virtue of his very presence, I think it pretty fair to surmise not only have we been ignored already, but also the ME/CFS expert researcher/clinician community, and the IOM report.
#MEAction is sharing all of the comments on that page with NIH. We have received text submissions for a few petitions, and will try to finish a single petition incorporating everyone's input in the next few days. I do believe that official channels will help though since NIH is now listening and (slowly.....) setting up communication processes. I realize I may be wrong, but I don't think this will be like the Lancet where Horton ignored all the controversy and said he couldn't respond because he was on vacation.
And Nath said the study is at the very beginning and everything is subject to change based on patient input, so now they have the opportunity to prove it.
Dialogue is the only way things get resolved. Sometimes protests and petitions are needed to get the dialogue started but ultimately if you can skip them you can still achieve the same result. Of course if we are ignored then they become a useful means of demonstating our objections.
Researchers should be agnostic
That never happens in medical research. Doctors & scientists want to help patients and when they test new treatments, they want a positive outcome. That's why study design is so important - you design the study to try to remove as much bias as possible.
Dr. Nath has no apparent background in psychology or ME, just a strong biomedical background. That is the type of researcher we need running a study, with input on study design from disease experts. When disease experts with heavy bias design and run a study, you get PACE.That never happens in medical research. Doctors & scientists want to help patients and when they test new treatments, they want a positive outcome.
Indeed, that's why everyone appears to be up in arms about Walitt. I don't think it's unreasonable to assume that the FMD control arm had something to do with his input given his now apparent bias.That's why study design is so important - you design the study to try to remove as much bias as possible.
According to what Dr. Nath said during his recent talk, they will be recruited from the CDC multisite clinicians, so:I have a question. From what pool will the study participants be drawn?
Dr Lucinda Bateman (Fatigue Consultation Clinic, UT)
Dr. Nancy Klimas (Center for Neuro Immune Medicine, FL)
Dr Andreas Kogelnik (Open Medicine Clinic, CA)
Dr Charles Lapp (Hunter-Hopkins Center, NC)
Dr. Benjamin Natelson (Pain and Fatigue Study Center, NY)
Dr Daniel Peterson (Sierra Internal Medicine Associates, NV)
Dr Richard Podell (Richard Podell Clinic, NJ)
Words fail. I wish I could unsee this.
he's saying doctor's training in the main consists of handing out drugs which of course does not restore health nor get to the root of an illness. So he sets out very clearly the extreme limits of traditional medical training - giving out drugs, after a very short office visit.Well, as physicians, we have a limited amount of time in the office and our training is to use medications to deal with the problems that we see in front of us. And fibromyalgia as a disorder defies all of that. It requires a lot more time and medications do not work very well. And if you try to adhere to how we’ve been trained to treat people, you’ll inevitably fail.